• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Cedara revenues surge

Article

A 47% jump in 2Q 2004 sales boosted revenues at Cedara Software to $12.1 million from $8.2 million in the same quarter of the previous year, driving net income for the quarter to $3.9 million compared with a net loss of $3.9 million in the previous

A 47% jump in 2Q 2004 sales boosted revenues at Cedara Software to $12.1 million from $8.2 million in the same quarter of the previous year, driving net income for the quarter to $3.9 million compared with a net loss of $3.9 million in the previous year's second quarter. For the six months ended Dec. 31, 2003, revenues were up 53% to $22.3 million from $14.6 million in the previous year. Net income for the six months was $5.6 million, compared with a net loss of $8 million in the previous year.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.